Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy

References

• Borges AF, Silva C, Coelho JFJ, et al. Oral films: current status and future perspectives: I — galenical development and quality attributes. J Control Release. 2015;206:1–19.
   PubMed Web of Science ®Google Scholar
• Karki S, Kim H, Na SJ, et al. Thin films as an emerging platform for drug delivery. Asian J Pharm Sci. 2016;11:559–574.
   Web of Science ®Google Scholar
• Foo WC, Khong YM, Gokhale R, et al. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film. Int J Pharm. 2018;539(1–2):165–174.
   PubMedGoogle Scholar
• Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci. 2015;75:2–9.
   PubMed Web of Science ®Google Scholar
• Scarpa M, Stegemann S, Hsiao WK, et al. Orodispersible films: towards drug delivery in special populations. Int J Pharm. 2017;523(1):327–335.
   PubMedGoogle Scholar
• Borges AF, Silva C, Coelho JFJ, et al. Oral films: current status and future perspectives. II — intellectual property, technologies and market needs. J Control Release. 2015;206:108–121.
   PubMed Web of Science ®Google Scholar
• Stegemann S, Ternik RL, Onder G, et al. Defining patient centric pharmaceutical drug product design. AAPS J. 2016;18(5):1047–1055.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Scarpa M, Kamlow M, et al. Patient acceptability of 3D printed medicines. Int J Pharm. 2017;530(1–2):71–78.
   PubMedGoogle Scholar
• Visser JC, Woerdenbag HJ, Hanff LM, et al. Personalized medicine in pediatrics: the clinical potential of orodispersible films. AAPS PharmSciTech. 2017;18(2):267–272.
   PubMed Web of Science ®Google Scholar
• Zajicek A, Fossler MJ, Barrett JS, et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS J. 2013;15(4):1072–1081.
   PubMed Web of Science ®Google Scholar
• Somogyi O, Meskó A, Csorba L, et al. Pharmaceutical counselling about different types of tablet-splitting methods based on the results of weighing tests and mechanical development of splitting devices. Eur J Pharm Sci. 2017;106:262–273.
   PubMed Web of Science ®Google Scholar
• Khatri P, Shah MK, Vora N. Formulation strategies for solid oral dosage form using 3D printing technology: a mini-review. J Drug Deliv Sci Technol. 2018;46:148–155.
   Web of Science ®Google Scholar
• Preis M, Breitkreutz J, Sandler N. Perspective: concepts of printing technologies for oral film formulations. Int J Pharm. 2015;494(2):578–584.
   PubMed Web of Science ®Google Scholar
• Cui M, Yang Y, Jia D, et al. Effect of novel internal structures on printability and drug release behavior of 3D printed tablets. J Drug Delivery Sci Technol. 2018;49:14–23.
   Web of Science ®Google Scholar
• Verstraete G, Samaro A, Grymonpré W, et al. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Int J Pharm. 2017;536(1):318–325.
   PubMedGoogle Scholar
• Sadia M, Arafat B, Ahmed W, et al. Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets. J Control Release. 2017;269:355–363.
   PubMed Web of Science ®Google Scholar
• Beck RCR, Chaves PS, Goyanes A, et al. 3D printed tablets loaded with polymeric nanocapsules: an innovative approach to produce customized drug delivery systems. Int J Pharm. 2017;528(1–2):268–279.
   PubMedGoogle Scholar
• Jamróz W, et al. 3D printed orodispersible films with Aripiprazole. Int J Pharm. 2017;533(2):413–420.
   PubMed Web of Science ®Google Scholar
• Buanz ABM, Belaunde CC, Soutari N, et al. Ink-jet printing versus solvent casting to prepare oral films: effect on mechanical properties and physical stability. Int J Pharm. 2015;494(2):611–618.
   PubMedGoogle Scholar
• Scoutaris N, Snowden M, Douroumis D. Taste masked thin films printed by jet dispensing. Int J Pharm. 2015;494(2):619–622.
   PubMedGoogle Scholar
• Edinger M, Bar-Shalom D, Sandler N, et al. QR encoded smart oral dosage forms by inkjet printing. Int J Pharm. 2017;536(1):138–145.
   PubMedGoogle Scholar
• Buanz ABM, Saunders MH, Basit AW, et al. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing. Pharm Res. 2011;28(10):2386–2392.
   PubMed Web of Science ®Google Scholar
• Janssen EM, Schliephacke R, Breitenbach A, et al. Drug-printing by flexographic printing technology—a new manufacturing; process for orodispersible films. Int J Pharm. 2013;441(1–2):818–825.
   PubMed Web of Science ®Google Scholar
• Holläder J, Hakala R, Suominen J, et al. 3D printed UV light cured polydimethylsiloxane devices for drug delivery. Int J Pharm. 2017;544(2):433–442.
   PubMedGoogle Scholar
• Thabet Y, Breitkreutz J. Orodispersible films: product transfer from lab-scale to continuous manufacturing. Int J Pharm. 2018;535(1–2):285–292.
   PubMedGoogle Scholar
• Singh-Franco D, Ghin HL, Robles GI, et al. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther. 2009;31(8):1664–1687.
   PubMed Web of Science ®Google Scholar
• XYZAL® (levocetirizine dihydrochloride) full formulation information. Belgium: UCB; 2020.
   Google Scholar
• Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94–107.
   PubMed Web of Science ®Google Scholar
• Sharma R, Kamboj S, Singh G, et al. Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance. Eur J Pharm Sci. 2016;84:55–69.
   PubMed Web of Science ®Google Scholar
• Mazumder S, Pavurala N, Manda P, et al. Quality by design approach for studying the impact of formulation and process variables on product quality of oral disintegrating films. Int J Pharm. 2017;527(1–2):151–160.
   PubMedGoogle Scholar
• Zhao Y, Quan P, Fang L. Preparation of an oral thin film containing meclizine hydrochloride: in vitro and in vivo evaluation. Int J Pharm. 2015;496(2):314–322.
   PubMedGoogle Scholar
• Shen BD, Shen CY, Yuan XD, et al. Development and characterization of an orodispersible film containing drug nanoparticles. Eur J Pharm Biopharm. 2013;85(3):1348–1356.
   PubMed Web of Science ®Google Scholar
• Nishigaki M, Kawahara K, Nawa M, et al. Development of fast dissolving oral film containing dexamethasone as an antiemetic medication: clinical usefulness. Int J Pharm. 2012;424(1–2):12–17.
   PubMed Web of Science ®Google Scholar
• Krull SM, Moreno J, Li M, et al. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading. Int J Pharm. 2017;523(1):33–41.
   PubMedGoogle Scholar
• Visser JC, Dohmen WMC, Hinrichs WLJ, et al. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films. Int J Pharm. 2015;485(1–2):70–76.
   PubMedGoogle Scholar
• Chinese Pharmacopoeia Committee. 2015. Pharmacopoeia of the People’s Republic of China. Vol. II and IV. Beijing (China): Chemical Industry Press.
   Google Scholar
• Zhenjie M, Junfeng B, Yan Z, et al. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone. Nanomedicine. 2018;13(11):1239–1253.
   PubMed Web of Science ®Google Scholar
• Planchette C, Pichler H, Wimmer-Teubenbacher M, et al. Printing medicines as orodispersible dosage forms: effect of substrate on the printed micro-structure. Int J Pharm. 2016;509(1–2):518–527.
   PubMed Web of Science ®Google Scholar
• Visser JC, Woerdenbag HJ, Crediet S, et al. Orodispersible films in individualized pharmacotherapy: the development of a formulation for pharmacy preparations. Int J Pharm. 2015;478(1):155–163.
   PubMedGoogle Scholar